See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides

Summary by Innate-pharma.com
Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides Fri, 05/23/2025 - 07:00 Press Release in English 230.44 KB Communiqué de presse en français 188.74 KB mathilde Thu, 05/22/2025
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

innate-pharma.cominnate-pharma.com

Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides

Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides Fri, 05/23/2025 - 07:00 Press Release in English 230.44 KB Communiqué de presse en français 188.74 KB mathilde Thu, 05/22/2025

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

innate-pharma.com broke the news in on Thursday, May 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Marseille icon

Marseille

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal